Jean-Marc Grosperrin
Europe Guide 2024
Band 1 : Pharma/Life Sciences: Corporate
Email address
[email protected]Contact number
+33 1 42 68 92 03Share profile
Band 1
About
Provided by Jean-Marc Grosperrin
Practice Areas
Jean-Marc Grosperrin, a partner in Dentons' Paris office, is primarily involved in French and cross-border acquisitions, private equity transactions and industrial M&A transactions. Jean-Marc regularly advises major international groups as well as mid-sized companies.
Besides advising French and foreign companies on their acquisitions or divestitures in France and abroad, he also represents investment funds and managers in leveraged transactions.
Jean-Marc is Global Life Science & Healthcare Leader and Co-head of the Europe and Paris Life Sciences groups. He also serves as a member of Dentons Europe Board.
Career
Joined Dentons (formerly Salans) in 2004
Started his career in 1998 at Willkie Farr & Gallagher, first in Paris and then in New York, where he concentrated on private equity acquisitions, mergers and restructurings issues.
Professional Memberships
Admitted to the Bar, Paris, 1998
Articles, highlights and press releases
2 items provided by Dentons
Dentons advises on the sale of Scalefast to ESW
Dentons advised US-based Scalefast, a key player in global e-commerce, on its sale to ESW, the global direct-to-consumer (DTC) e-commerce leader.
Partner Jean-Marc Grosperrin elected as member of Dentons Europe Board
Paris-based partner Jean-Marc Grosperrin has been elected as a Member of the Board of Dentons Europe for a three-year term. In addition to his new supervisory role, he will continue to protect the interests of his clients and to serve as Co-chair of the Global Life Sciences group.
Dentons advises on the sale of Scalefast to ESW
Dentons advised US-based Scalefast, a key player in global e-commerce, on its sale to ESW, the global direct-to-consumer (DTC) e-commerce leader.
Partner Jean-Marc Grosperrin elected as member of Dentons Europe Board
Paris-based partner Jean-Marc Grosperrin has been elected as a Member of the Board of Dentons Europe for a three-year term. In addition to his new supervisory role, he will continue to protect the interests of his clients and to serve as Co-chair of the Global Life Sciences group.